weight loss program with semaglutide glp-1 ozempic in laguna beach Urgent Care GLP-1 Wight Loss Program

(2023), overall weight reduction at each retatrutide dose was modestly lower than in the non-diabetic obesity cohort approximately 16.9% at 12mg vs

Once-Weekly Semaglutide in Adults With Alcohol Use Disorder

Figure 2: Photograph of Claude Bernard, unknown date

Just reach out to us

In December 2025, the Food and Drug Administration (FDA) approved an oral pill form of Wegovy for weight loss, and in April 2026 approved the once-daily oral GLP-1 drug Foundayo (orforglipron) also for weight loss

With medical overview and convenient online access to a provider, we make it easy to stay on track and feel supported every step of the way